ArticleCardiovascular diabetology2019

Empagliflozin, a sodium glucose co-transporter-2 inhibitor, alleviates atrial remodeling and improves mitochondrial function in high-fat diet/streptozotocin-induced diabetic rats.

Qingmiao Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.